|
- 2016
Effect of Ivacaftor on Objective and Subjective Measures of Cough in Patients with Cystic FibrosisDOI: 10.2174/1874306401610010105 Keywords: Cystic fibrosis, Cough, Ivacaftor, Gastro-oesophageal reflux, G551D mutation, Lung function Abstract: Cough is a major symptom in cystic fibrosis. Ivacaftor is a novel drug which targets the G551D mutation and has been demonstrated to improve lung function and weight in the long term. It also improves symptoms of extra-oesophageal reflux. We wanted to evaluate the effect of ivacaftor on cough in cystic fibrosis
|